Antihyperthermic treatment decreases perihematomal hypodensity
Identificadores
Identificadores
Visualización o descarga de ficheros
Visualización o descarga de ficheros
Fecha de publicación
2020Título de revista
NEUROLOGY
Tipo de contenido
Journal Article
DeCS
pronóstico | dipirona | anciano | temperatura corporal | antipiréticos | hemorragia cerebral | estudios retrospectivos | hematoma | mediana edad | humanos | fiebre | acetaminofénMeSH
Body Temperature | Fever | Middle Aged | Humans | Cerebral Hemorrhage | Hematoma | Dipyrone | Acetaminophen | Retrospective Studies | Aged | Prognosis | AntipyreticsResumen
OBJECTIVE: To investigate the effect on perihematomal hypodensity and outcome of a decrease in body temperature in the first 24 hours in patients with intracerebral hemorrhage (ICH). METHODS: In this retrospective study on a prospectively registered database, among the 1,100 patients, 795 met all the inclusion criteria. Temperature variations in the first 24 hours and perihematomal hypodensity (PHHD) were recorded. Patients >/=37.5 degrees C were treated with antihyperthermic drugs for at least 48 hours. The main objective was to determine the association among temperature variation, PHHD, and outcome at 3 months. RESULTS: The decrease in temperature in the first 24 hours increased the possibility of good outcome 11-fold. Temperature decrease, lower PHHD volume, and a good outcome were observed in 31.8% of the patients who received antihyperthermic treatment. CONCLUSION: The administration of early antihyperthermic treatment in patients with spontaneous ICH with a basal axillary temperature >/=37.5 degrees C resulted in good outcome in a third of the treated patients.